Geopolitics Alpha

Biofrontera (BFRIW): filings, insider buys & geopolitical news

In the last 30 days, Geopolitics Alpha logged 1 item on Biofrontera: 0 news stories, 1 SEC filing and 0 fund or insider trade reports. The latest filing was logged 13 Nov 2026: 8-K - Biofrontera Inc. (0001858685) (Filer).

Government contracts

No federal prime contract obligations are matched to Biofrontera in USAspending.gov for the last five years, and no Department of Defense contract announcements name it in the past year. See the largest government contractors.

BFRIW share price, last 12 months

Close $0.03 on Aug 28, 2026, -73.2% since Nov 17, 2025 (range $0.02 to $0.11, daily closes).

What changed for Biofrontera (BFRIW)

In the last 30 days, Geopolitics Alpha logged 1 item on Biofrontera: 0 news stories, 1 SEC filing and 0 fund or insider trade reports. The latest filing was logged 13 Nov 2026: 8-K - Biofrontera Inc. (0001858685) (Filer).

Latest SEC filings

Latest fund & insider buys and sales

None on record yet.

Latest geopolitical & market news

None on record yet.

Congressional trades in BFRIW

Trades in BFRIW that members of Congress have publicly reported, newest filing first.

No congressional trades are stored for this view yet.

All congressional stock trades →

Geopolitical news for BFRIW

Everything on BFRIW, newest first

Frequently asked questions

Does Biofrontera have government contracts?

No federal prime contract obligations are matched to Biofrontera (BFRIW) in USAspending.gov for the last five years. Subcontracts are not included.

Where does the contract data come from?

USAspending.gov (the official source of U.S. federal spending data) and the Department of Defense's daily contract announcements. Both are public domain and refreshed daily here.

What geopolitical news affects BFRIW?

This page lists every Geopolitics Alpha note that names BFRIW as exposed to an event, with the reason it is exposed.

Has Congress traded BFRIW?

The table above lists trades in BFRIW that members of Congress have publicly reported, with a link to each official filing.

Is this investment advice?

No. We show news, exposure and past price moves. Nothing here is a recommendation.